Literature DB >> 15001394

Nitric oxide inhibits prooxidant actions of uric acid during copper-mediated LDL oxidation.

Silvia M Sanguinetti1, Carlos Batthyány, Andrés Trostchansky, Horacio Botti, Graciela I López, Regina L W Wikinski, Homero Rubbo, Laura E Schreier.   

Abstract

Interactions between uric acid and physiologically relevant fluxes of nitric oxide ((?)NO) during copper-mediated low-density lipoprotein (LDL) oxidation were evaluated. In the absence of (?)NO, a dual pro- and antioxidant action of uric acid was evident: low concentrations of uric acid enhanced lipid oxidation and alpha-tocopherol consumption, while its protective role was observed at higher concentrations. The prooxidant effects of uric acid were mostly related to its copper-reducing ability to form Cu(+), an initiator of lipid oxidation processes. While the prooxidant action of uric acid was completely inhibited by (?)NO, the antioxidant action of (?)NO was slightly counterbalanced by uric acid. Enhancement of alpha-tocopherol consumption by uric acid was inhibited in the presence of (?)NO while additive antioxidant effects between (?)NO and uric acid were observed in conditions where uric acid spared alpha-tocopherol. Altogether, these results suggest that in the artery wall, the (?)NO/uric acid pair may exert antioxidant actions on LDL, even if increased amounts of redox active copper were available at conditions favoring prooxidant activities of uric acid.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001394     DOI: 10.1016/j.abb.2003.12.034

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress.

Authors:  Christine Gersch; Sergiu P Palii; Witcha Imaram; Kyung Mee Kim; S Ananth Karumanchi; Alexander Angerhofer; Richard J Johnson; George N Henderson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2009-02       Impact factor: 1.381

2.  Naturally high plasma glucose levels in mourning doves (Zenaida macroura) do not lead to high levels of reactive oxygen species in the vasculature.

Authors:  Christina L Smith; Matthew Toomey; Benjimen R Walker; Eldon J Braun; Blair O Wolf; Kevin McGraw; Karen L Sweazea
Journal:  Zoology (Jena)       Date:  2011-05-19       Impact factor: 2.240

3.  Effect of single bout of maximal exercise on plasma antioxidant status and paraoxonase activity in young sportsmen.

Authors:  A Otocka-Kmiecik; M Lewandowski; R Stolarek; U Szkudlarek; D Nowak; M Orlowska-Majdak
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 4.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

5.  Inactivation of nitric oxide by uric acid.

Authors:  Christine Gersch; Sergiu P Palii; Kyung Mee Kim; Alexander Angerhofer; Richard J Johnson; George N Henderson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-08       Impact factor: 1.381

6.  Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Nutr Metab (Lond)       Date:  2004-10-19       Impact factor: 4.169

7.  Association between serum copper levels and prevalence of hyperuricemia: a cross-sectional study.

Authors:  Ting Jiang; Dongxing Xie; Jing Wu; Hongyi He; Haochen Wang; Ning Wang; Zhenglei Zhu; Yilun Wang; Tuo Yang
Journal:  Sci Rep       Date:  2020-05-26       Impact factor: 4.379

8.  Role of Serum Uric Acid as a Protective Biomarker in Patients with Different Histopathological Grades of Oral Squamous Cell Carcinoma: a Case-Control Study.

Authors:  Soheila Manifar; Arezoo Rahimzamani; Mohammad Shirkhoda; Mohammad Nikkhah Ghamsari; Mahin Bakhshi
Journal:  Biomed Res Int       Date:  2020-09-12       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.